- Joined
- Nov 16, 2015
- Messages
- 78
- Reaction score
- 4
B1 receptor activation increases Heart Rate and Contractility, which increases Cardiac output. It also increases systolic arterial pressure (how is this systolic pressure increased?).
B2 receptor activation causes vasodilation, which decreases systemic vascular resistance, which decreases Arterial dyastolic pressure. (any effect on systolic arterial pressure?)
Dobutamine acts on B1 receptors > B2 receptors. (bigger effect on B1).
So, it increases HR, contractility and systolic arterial pressure (again, how?), and has a mild vasodilatory effect which may decrease arterial dyastolic pressure: pulse pressure is increased.
Isoprotenerol acts on B1 receptors = B2 receptors. (same intensity of effect on both).
So, it increases HR, contractility, and keeps arterial systolic pressure relatively unchanged (same thing: why?). It also has vasodilatory effects that decrease systemic vascular resistance and this decreases dyastolic arterial pressure and decreases mean arterial pressure. Pulse pressure is also increased.
Hope you can help guys, thank you!
B2 receptor activation causes vasodilation, which decreases systemic vascular resistance, which decreases Arterial dyastolic pressure. (any effect on systolic arterial pressure?)
Dobutamine acts on B1 receptors > B2 receptors. (bigger effect on B1).
So, it increases HR, contractility and systolic arterial pressure (again, how?), and has a mild vasodilatory effect which may decrease arterial dyastolic pressure: pulse pressure is increased.
Isoprotenerol acts on B1 receptors = B2 receptors. (same intensity of effect on both).
So, it increases HR, contractility, and keeps arterial systolic pressure relatively unchanged (same thing: why?). It also has vasodilatory effects that decrease systemic vascular resistance and this decreases dyastolic arterial pressure and decreases mean arterial pressure. Pulse pressure is also increased.
Hope you can help guys, thank you!